Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside—a Comprehensive Review
出版年份 2015 全文链接
标题
Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside—a Comprehensive Review
作者
关键词
Arthritis, Inflammation, Osteoclast, Osteoblast, Cytokine, IL-17
出版物
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
Volume 51, Issue 1, Pages 27-47
出版商
Springer Nature
发表日期
2015-12-03
DOI
10.1007/s12016-015-8522-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition
- (2015) Christoph Garbers et al. CURRENT OPINION IN IMMUNOLOGY
- The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis
- (2015) Sandra M.J. Paulissen et al. CYTOKINE
- Erratum: The IL-23–IL-17 axis in inflammatory arthritis
- (2015) Erik Lubberts Nature Reviews Rheumatology
- The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis
- (2015) Maarten Van Roy et al. ARTHRITIS RESEARCH & THERAPY
- Risk of Hospitalized Infection Among Rheumatoid Arthritis Patients Concurrently Treated With a Biologic Agent and Denosumab
- (2015) Jeffrey R. Curtis et al. Arthritis & Rheumatology
- A Randomized, Double-Blind, Placebo-Controlled, Twelve-Week, Dose-Ranging Study of Decernotinib, an Oral Selective JAK-3 Inhibitor, as Monotherapy in Patients With Active Rheumatoid Arthritis
- (2015) Roy M. Fleischmann et al. Arthritis & Rheumatology
- IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis
- (2014) Iannis E Adamopoulos et al. ANNALS OF THE RHEUMATIC DISEASES
- The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
- (2014) D L Boyle et al. ANNALS OF THE RHEUMATIC DISEASES
- Sirukumab, a human anti-interleukin-6 monoclonal antibody: a randomised, 2-part (proof-of-concept and dose-finding), phase II study in patients with active rheumatoid arthritis despite methotrexate therapy
- (2014) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Small-molecule therapeutics in rheumatoid arthritis: Scientific rationale, efficacy and safety
- (2014) Florian M.P. Meier et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Canonical Wnt signalling activates TAZ through PP1A during osteogenic differentiation
- (2014) M R Byun et al. CELL DEATH AND DIFFERENTIATION
- Odanacatib Treatment Affects Trabecular and Cortical Bone in the Femur of Postmenopausal Women: Results of a Two-Year Placebo-Controlled Trial
- (2014) Klaus Engelke et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1/2 inhibitor, in healthy volunteers
- (2014) Jack G. Shi et al. JOURNAL OF CLINICAL PHARMACOLOGY
- IL-23 Inhibits Osteoclastogenesis Indirectly through Lymphocytes and Is Required for the Maintenance of Bone Mass in Mice
- (2014) J. M. W. Quinn et al. JOURNAL OF IMMUNOLOGY
- IL-23 Induces Receptor Activator of NF- B Ligand Expression on CD4+ T Cells and Promotes Osteoclastogenesis in an Autoimmune Arthritis Model
- (2014) J. H. Ju et al. JOURNAL OF IMMUNOLOGY
- JAK2-STAT3 Blockade by AG490 Suppresses Autoimmune Arthritis in Mice via Reciprocal Regulation of Regulatory T Cells and Th17 Cells
- (2014) J.-S. Park et al. JOURNAL OF IMMUNOLOGY
- Crosstalk among IL-23 and DNAX Activating Protein of 12 kDa–Dependent Pathways Promotes Osteoclastogenesis
- (2014) Hyun-Seock Shin et al. JOURNAL OF IMMUNOLOGY
- Recapitulating endochondral ossification: a promising route toin vivobone regeneration
- (2014) Emmet M. Thompson et al. Journal of Tissue Engineering and Regenerative Medicine
- Discovery and characterization of olokizumab
- (2014) Stevan Shaw et al. mAbs
- TNFα but not IL-17 is critical in the pathogenesis of rheumatoid arthritis spontaneously occurring in a unique FcγRIIB-deficient mouse model
- (2014) Hideki Okazaki et al. Modern Rheumatology
- Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures
- (2014) Sofia Movérare-Skrtic et al. NATURE MEDICINE
- Tofacitinib versus Methotrexate in Rheumatoid Arthritis
- (2014) Eun Bong Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial
- (2014) H. G. Bone et al. OSTEOPOROSIS INTERNATIONAL
- Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis
- (2014) Barbara Hauser et al. RHEUMATOLOGY
- Dysregulated B Cell Expression of RANKL and OPG Correlates with Loss of Bone Mineral Density in HIV Infection
- (2014) Kehmia Titanji et al. PLoS Pathogens
- A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti-Interleukin-17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors
- (2014) Mark C. Genovese et al. Arthritis & Rheumatology
- The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells
- (2013) Satoshi Kubo et al. ANNALS OF THE RHEUMATIC DISEASES
- Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial
- (2013) Tom W J Huizinga et al. ANNALS OF THE RHEUMATIC DISEASES
- Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis
- (2013) Beatriz Orosa et al. ANNALS OF THE RHEUMATIC DISEASES
- Periarticular Bone Loss in Antigen-Induced Arthritis
- (2013) Cecilia Engdahl et al. ARTHRITIS AND RHEUMATISM
- Anti-interleukin-6 receptor antibody prevents systemic bone mass loss via reducing the number of osteoclast precursors in bone marrow in a collagen-induced arthritis model
- (2013) Keisuke Tanaka et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Preclinical Characterization of GLPG0634, a Selective Inhibitor of JAK1, for the Treatment of Inflammatory Diseases
- (2013) L. Van Rompaey et al. JOURNAL OF IMMUNOLOGY
- Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
- (2013) Gerd R Burmester et al. LANCET
- Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis
- (2013) Noriko Komatsu et al. NATURE MEDICINE
- IL-23 Dependent and Independent Stages of Experimental Arthritis: No Clinical Effect of Therapeutic IL-23p19 Inhibition in Collagen-induced Arthritis
- (2013) Ferry Cornelissen et al. PLoS One
- Engineering of a functional bone organ through endochondral ossification
- (2013) C. Scotti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Absence of Interleukin-17 Receptor A Signaling Prevents Autoimmune Inflammation of the Joint and Leads to a Th2-like Phenotype in Collagen-Induced Arthritis
- (2013) Odilia B. J. Corneth et al. Arthritis & Rheumatology
- Impact of Inflammation on the Osteoblast in Rheumatic Diseases
- (2013) Rebecca Baum et al. Current Osteoporosis Reports
- C57BL/6 mice need MHC class II Aq to develop collagen-induced arthritis dependent on autoreactive T cells
- (2012) Johan Bäcklund et al. ANNALS OF THE RHEUMATIC DISEASES
- A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate
- (2012) P Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production
- (2012) Timothy P. LaBranche et al. ARTHRITIS AND RHEUMATISM
- Interleukin-17A stimulates granulocyte-macrophage colony-stimulating factor release by murine osteoblasts in the presence of 1,25-dihydroxyvitamin D3and inhibits murine osteoclast development in vitro
- (2012) Deepak Balani et al. ARTHRITIS AND RHEUMATISM
- Tumor necrosis factor-inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor-driven model of rheumatoid arthritis
- (2012) Nikolaus B. Binder et al. ARTHRITIS AND RHEUMATISM
- Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry
- (2012) Fabiola Atzeni et al. AUTOIMMUNITY REVIEWS
- IL-17-deficient allogeneic bone marrow transplantation prevents the induction of collagen-induced arthritis in DBA/1J mice
- (2012) Min-Jung Park et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- IL-17 producing T cells in mouse models of multiple sclerosis and rheumatoid arthritis
- (2012) Bernadette Pöllinger JOURNAL OF MOLECULAR MEDICINE-JMM
- Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
- (2012) David L. Lacey et al. NATURE REVIEWS DRUG DISCOVERY
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
- (2012) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
- (2012) Craig Leonardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
- (2012) Ronald F. van Vollenhoven et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis
- (2011) Maria J H Boumans et al. ANNALS OF THE RHEUMATIC DISEASES
- Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway
- (2011) Melissa M. Matzelle et al. ARTHRITIS AND RHEUMATISM
- A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone
- (2011) Joel M. Kremer et al. ARTHRITIS AND RHEUMATISM
- In-vivo generation of bone via endochondral ossification by in-vitro chondrogenic priming of adult human and rat mesenchymal stem cells
- (2011) Eric Farrell et al. BMC MUSCULOSKELETAL DISORDERS
- Anti IL-17A therapy inhibits bone loss in TNF-α-mediated murine arthritis by modulation of the T-cell balance
- (2011) Karin Zwerina et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IL-27 suppresses RANKL expression in CD4+ T cells in part through STAT3
- (2011) Sadahiro Kamiya et al. IMMUNOLOGY LETTERS
- The transcriptome of fracture healing defines mechanisms of coordination of skeletal and vascular development during endochondral bone formation
- (2011) Rachel Grimes et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Th17 Cells, Not IL-17+ T Cells, Drive Arthritic Bone Destruction in Mice and Humans
- (2011) B. Pollinger et al. JOURNAL OF IMMUNOLOGY
- IL-23 Is Critical for Induction of Arthritis, Osteoclast Formation, and Maintenance of Bone Mass
- (2011) I. E. Adamopoulos et al. JOURNAL OF IMMUNOLOGY
- Whole-Molecule Antibody Engineering: Generation of a High-Affinity Anti-IL-6 Antibody with Extended Pharmacokinetics
- (2011) Donna K. Finch et al. JOURNAL OF MOLECULAR BIOLOGY
- Circulating Dickkopf-1 Is Correlated with Bone Erosion and Inflammation in Rheumatoid Arthritis
- (2011) SHI-YAO WANG et al. JOURNAL OF RHEUMATOLOGY
- Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis
- (2011) G. Wheater et al. OSTEOPOROSIS INTERNATIONAL
- Receptor activator of nuclear factor kappa B ligand serum and synovial fluid level. A comparative study between rheumatoid arthritis and osteoarthritis
- (2011) Abdou S. Ellabban et al. RHEUMATOLOGY INTERNATIONAL
- A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis
- (2011) Kristine L Stump et al. ARTHRITIS RESEARCH & THERAPY
- Chondrogenic pre-induction of human mesenchymal stem cells on β-TCP: Enhanced bone quality by endochondral heterotopic bone formation
- (2010) Patricia Janicki et al. Acta Biomaterialia
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial
- (2010) P. P. Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis
- (2010) Gaetano Zizzo et al. CLINICAL IMMUNOLOGY
- Safety profile of abatacept in rheumatoid arthritis: A review
- (2010) Majed Khraishi et al. CLINICAL THERAPEUTICS
- Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation
- (2010) Shigeru Kotake et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Cathepsin K inhibitors prevent bone loss in estrogen-deficient rabbits
- (2010) Brenda L Pennypacker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect
- (2010) John A Eisman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050
- (2010) J. S. Fridman et al. JOURNAL OF IMMUNOLOGY
- NIK Stabilization in Osteoclasts Results in Osteoporosis and Enhanced Inflammatory Osteolysis
- (2010) Chang Yang et al. PLoS One
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients
- (2010) A. Deodhar et al. ARTHRITIS CARE & RESEARCH
- Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial
- (2009) J H Coombs et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-1 is essential for systemic inflammatory bone loss
- (2009) K Polzer et al. ANNALS OF THE RHEUMATIC DISEASES
- Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo
- (2009) Roland Axmann et al. ARTHRITIS AND RHEUMATISM
- Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritis
- (2009) R. M. Fleischmann ARTHRITIS AND RHEUMATISM
- The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo
- (2009) Joel M. Kremer et al. ARTHRITIS AND RHEUMATISM
- Pathogenic antibody recognition of cartilage
- (2009) Kutty Selva Nandakumar CELL AND TISSUE RESEARCH
- Inhibition of cathepsin K reduces bone erosion, cartilage degradation and inflammation evoked by collagen-induced arthritis in mice
- (2009) Lena Svelander et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Bone remodeling in rheumatic disease: a question of balance
- (2009) Nicole C. Walsh et al. IMMUNOLOGICAL REVIEWS
- Osteoblast Function Is Compromised at Sites of Focal Bone Erosion in Inflammatory Arthritis
- (2009) Nicole C Walsh et al. JOURNAL OF BONE AND MINERAL RESEARCH
- IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-α antibody: A novel mechanism of osteoclastogenesis by IL-17
- (2009) Toru Yago et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Chondrogenic Priming of Human Bone Marrow Stromal Cells: A Better Route to Bone Repair?
- (2009) Eric Farrell et al. TISSUE ENGINEERING PART C-METHODS
- CTLA-4 directly inhibits osteoclast formation
- (2008) R Axmann et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies
- (2008) E Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor–transgenic mice
- (2008) Uta Schurigt et al. ARTHRITIS AND RHEUMATISM
- Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate
- (2008) Joel M. Kremer et al. ARTHRITIS AND RHEUMATISM
- Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial
- (2008) Stanley B. Cohen et al. ARTHRITIS AND RHEUMATISM
- Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis
- (2008) Sonja Herman et al. ARTHRITIS AND RHEUMATISM
- IL-6 receptor expression and IL-6 effects change during osteoblast differentiation
- (2008) Yan Li et al. CYTOKINE
- IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-κB (RANK) expression in myeloid precursor cells
- (2008) Li Chen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/β-catenin signalling
- (2008) Ni Tang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Endochondral bone tissue engineering using embryonic stem cells
- (2008) J. M. Jukes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune regulation of bone loss by Th17 cells
- (2008) Iannis E Adamopoulos et al. ARTHRITIS RESEARCH & THERAPY
- Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritis
- (2008) Anthony J Milici et al. ARTHRITIS RESEARCH & THERAPY
- Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial
- (2007) H K Genant et al. ANNALS OF THE RHEUMATIC DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now